37 studies found for:    " August 29, 2012":" September 28, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 29, 2012":" September 28, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique
Conditions: Anemia;   Fever;   HIV Positive
Intervention:
2 Completed Efficacy of HIV Post-Test Support for ANC in South Africa
Conditions: HIV;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Enhanced Counseling;   Behavioral: Standard of Care
3 Unknown  Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients
Condition: HIV Infection
Intervention: Procedure: colonoscopy with endoscopic biopsies
4 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
5 Unknown  Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Conditions: HIV Infection;   Adverse Drug Reaction;   Quality of Life
Intervention: Drug: Raltegravir switch
6 Withdrawn A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection
Condition: Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Intervention: Drug: No intervention
7 Recruiting Brain Imaging for HIV-Associated Thinking and Mood Disorders
Conditions: Human Immunodeficiency Virus;   Neurocognitive Impairment
Intervention:
8 Unknown  A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
Conditions: Infection;   HIV
Intervention: Drug: Truvada and Isentress
9 Completed A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Conditions: Liver Fibrosis;   Hepatitis C;   HIV;   HIV/HCV Co-infection
Intervention: Biological: Simtuzumab
10 Completed Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe
Conditions: Circumcision Adult;   HIV CDC Category B2;   HIV Infections
Intervention: Device: PrePex™ device
11 Recruiting Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
Condition: HIV
Intervention: Drug: (FDC) ELV/COBI/FTC/TDF
12 Active, not recruiting Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Conditions: Cardiovascular Diseases;   HIV
Intervention:
13 Unknown  Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Conditions: Hyperlipidemia;   HIV
Interventions: Drug: Pitavastatin;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Efavirenz
14 Unknown  Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
Conditions: Pregnancy;   HIV
Intervention: Procedure: Integrated FP/PNC service delivery
15 Completed HIV Prevention for Injecting Drug Users in Kazakhstan
Conditions: HIV;   AIDS
Interventions: Behavioral: Couples Based HIV/STI Risk Reduction Intervention (CHSR);   Behavioral: Renaissance Wellness Promotion (WP)
16 Completed Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU
Condition: HIV
Interventions: Behavioral: Individual level;   Behavioral: Structural level;   Behavioral: Individual level standard of care;   Behavioral: Structural level standard of care
17 Completed Increasing Availability and Acceptability of Circumcision in Zambia
Condition: HIV
Intervention: Behavioral: MC and sexual risk reduction
18 Recruiting Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana
Conditions: Tuberculosis;   HIV
Intervention:
19 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
20 Completed Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years